These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 6138466
21. Prevention of sudden death using beta-blockers. Review of possible contributory actions. Olsson G, Rydén L. Circulation; 1991 Dec; 84(6 Suppl):VI33-7. PubMed ID: 1683608 [Abstract] [Full Text] [Related]
22. [Which anti-ischemic treatment can be prescribed during and after the acute phase of myocardial infarction?]. Delahaye F, Genoud JL, Colin C, Landrivon G, Ecochard R, Desseigne P, Pinzani A, André-Fouët X, Delaye J. Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1567-74. PubMed ID: 1363772 [Abstract] [Full Text] [Related]
23. Beta-blocker underuse in secondary prevention of myocardial infarction. Everly MJ, Heaton PC, Cluxton RJ. Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768 [Abstract] [Full Text] [Related]
24. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group. Second Chinese Cardiac Study (CCS-2) Collaborative Group. J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013 [Abstract] [Full Text] [Related]
25. [Calcium antagonists and coronary heart disease. An overview]. Gasser R, Eber B, Schwarz T, Schafhalter E, Klein W. Wien Med Wochenschr; 1993 Dec; 143(19-20):500-9. PubMed ID: 8135032 [Abstract] [Full Text] [Related]
26. Beta-adrenergic mechanisms during severe myocardial ischemia and evolving infarction. Willerson JT, Buja LM. Postgrad Med; 1988 Feb 29; Spec No():27-32. PubMed ID: 2894660 [Abstract] [Full Text] [Related]
27. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients. Hansen O, Johansson BW. J Hypertens Suppl; 1993 Jun 29; 11(4):S55-60. PubMed ID: 8104242 [Abstract] [Full Text] [Related]
28. Comprehensive drug management of angina pectoris. Pepine CJ, Feldman RL, Conti CR. Cardiovasc Clin; 1984 Jun 29; 14(3):139-51. PubMed ID: 6144388 [Abstract] [Full Text] [Related]
35. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction. Andersen SS, Hansen ML, Gislason GH, Folke F, Schramm TK, Fosbøl E, Sørensen R, Rasmussen S, Abildstrøm SZ, Madsen M, Køber L, Torp-Pedersen C. Cardiology; 2009 Sep 15; 112(2):144-50. PubMed ID: 18612201 [Abstract] [Full Text] [Related]
36. beta-Blockers and myocardial infarction. Moser M, Gorlin R. Arch Intern Med; 1982 Sep 15; 142(9):1618-9. PubMed ID: 6126165 [No Abstract] [Full Text] [Related]
37. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population. Fernandes AW, Madhavan SS, Amonkar MM. Clin Ther; 2005 May 15; 27(5):630-45. PubMed ID: 15978313 [Abstract] [Full Text] [Related]
38. [Secondary prevention after myocardial infarction in the aged (author's transl)]. Michel D. Aktuelle Gerontol; 1982 Jul 15; 12(4):149-54. PubMed ID: 6126140 [Abstract] [Full Text] [Related]